Clinical Trial Update: Effects of Lemborexant as a Treatment for Moderate-to-severe OSA Patients With Low Arousal Threshold [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting the completion of a Phase 1/2 study evaluating lemborexant for moderate-to-severe obstructive sleep apnea with low arousal thres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Lemborexant (lemborexant)

Snippet

Sponsor: Chulalongkorn University | Conditions: OSA | Phase 1, Phase 2 | Status: COMPLETED